Tevogen Bio Holdings Stock Performance
| TVGN Stock | 1.42 0.06 4.41% |
Tevogen Bio holds a performance score of 10 on a scale of zero to a hundred. The entity has a beta of -3.18, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Tevogen Bio are expected to decrease by larger amounts. On the other hand, during market turmoil, Tevogen Bio is expected to outperform it. Use Tevogen Bio Holdings semi variance, as well as the relationship between the daily balance of power and price action indicator , to analyze future returns on Tevogen Bio Holdings.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Tevogen Bio Holdings are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain technical and fundamental indicators, Tevogen Bio displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Tevogen Bio Plans to Share 1B Revenue Potential of its Pipeline Portfolio Beginning Week of October 14, 2024 | 10/11/2024 |
2 | Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly 1 Billion in Launch Year and Cumulative 5-Year Estimate Between 18 Billion and 22 Billion | 10/21/2024 |
3 | Tevogen Bios Effort in Artificial Intelligence, Tevogen AI, Joins Microsoft for Startups, Begins Accelerating drug Development | 10/23/2024 |
4 | Short Interest in Tevogen Bio Holdings Inc. Expands By 450.9 | 10/25/2024 |
5 | Philips Posts Weak Earnings, Joins Clear Channel Outdoor And Other Big Stocks Moving Lower In Mondays Pre-Market Session | 10/28/2024 |
6 | Tevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI into Preclinical Processes, Accelerating Drug Development and Reducing Costs | 10/31/2024 |
7 | Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Companys Novel Business Model as Key to Sustainable Success ... | 11/05/2024 |
8 | Tevogen Founder Reflects on Importance of Preserving Shareholder Value While Navigating Growth as it Prepares to File Quarterly Financials | 11/14/2024 |
9 | Tevogen Bio Reports Third Quarter 2024 Financial Results Highlights Significantly Improved ... | 11/19/2024 |
| Begin Period Cash Flow | 129.2 K |
Tevogen |
Tevogen Bio Relative Risk vs. Return Landscape
If you would invest 58.00 in Tevogen Bio Holdings on August 23, 2024 and sell it today you would earn a total of 84.00 from holding Tevogen Bio Holdings or generate 144.83% return on investment over 90 days. Tevogen Bio Holdings is currently generating 3.54% in daily expected returns and assumes 27.1175% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Tevogen, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Tevogen Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tevogen Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Tevogen Bio Holdings, and traders can use it to determine the average amount a Tevogen Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1305
| Best Portfolio | Best Equity | |||
| Good Returns | TVGN | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 27.12 actual daily | 96 96% of assets are less volatile |
Expected Return
| 3.54 actual daily | 70 70% of assets have lower returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Tevogen Bio is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tevogen Bio by adding it to a well-diversified portfolio.
Tevogen Bio Fundamentals Growth
Tevogen Stock prices reflect investors' perceptions of the future prospects and financial health of Tevogen Bio, and Tevogen Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tevogen Stock performance.
| Return On Asset | -0.83 | ||||
| Current Valuation | 258.98 M | ||||
| Shares Outstanding | 164.61 M | ||||
| EBITDA | 188.71 K | ||||
| Net Income | (67.33 K) | ||||
| Total Debt | 1.63 M | ||||
| Cash Flow From Operations | (1.38 M) | ||||
| Market Capitalization | 164.61 M | ||||
| Total Asset | 17.04 M | ||||
| Retained Earnings | (17.38 M) | ||||
| Working Capital | (2.65 M) | ||||
About Tevogen Bio Performance
By examining Tevogen Bio's fundamental ratios, stakeholders can obtain critical insights into Tevogen Bio's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Tevogen Bio is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Equity | 0.10 | 0.09 |
Things to note about Tevogen Bio Holdings performance evaluation
Checking the ongoing alerts about Tevogen Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Tevogen Bio Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Tevogen Bio Holdings is way too risky over 90 days horizon | |
| Tevogen Bio Holdings may become a speculative penny stock | |
| Tevogen Bio Holdings appears to be risky and price may revert if volatility continues | |
| Tevogen Bio Holdings was previously known as Semper Paratus Acquisition and was traded on NASDAQ Exchange under the symbol LGST. | |
| Net Loss for the year was (67.33 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Tevogen Bio generates negative cash flow from operations | |
| About 97.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: Tevogen Bio Reports Third Quarter 2024 Financial Results Highlights Significantly Improved ... |
- Analyzing Tevogen Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tevogen Bio's stock is overvalued or undervalued compared to its peers.
- Examining Tevogen Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Tevogen Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tevogen Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Tevogen Bio's stock. These opinions can provide insight into Tevogen Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tevogen Bio Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tevogen Bio. If investors know Tevogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tevogen Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets (0.83) |
The market value of Tevogen Bio Holdings is measured differently than its book value, which is the value of Tevogen that is recorded on the company's balance sheet. Investors also form their own opinion of Tevogen Bio's value that differs from its market value or its book value, called intrinsic value, which is Tevogen Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tevogen Bio's market value can be influenced by many factors that don't directly affect Tevogen Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tevogen Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tevogen Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tevogen Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.